Corient Private Wealth’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Corient Private Wealth’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$996K	Buy	+4,016	New	+$865K	﹤0.01%	1822
2026 Q1	–	Sell	-3,410	Closed	-$707K	–	2880
2025 Q4	$707K	Sell	3,410 -45	-1%	-$8.99K	﹤0.01%	1683
2025 Q3	$619K	Sell	3,455 -494	-13%	-$84.1K	﹤0.01%	1678
2025 Q2	$637K	Buy	+3,949	New	+$629K	﹤0.01%	1578
2024 Q4	–	Sell	-4,727	Closed	-$813K	–	2409
2024 Q3	$813K	Sell	4,727 -571	-11%	-$94.5K	﹤0.01%	1504
2024 Q2	$816K	Sell	5,298 -3,193	-38%	-$479K	﹤0.01%	1409
2024 Q1	$1.31M	Sell	8,491 -2,221	-21%	-$339K	﹤0.01%	1221
2023 Q4	$1.69M	Buy	10,712 +64	+0.6%	+$9.19K	﹤0.01%	1075
2023 Q3	$1.56M	Sell	10,648 -26	-0.2%	-$3.96K	﹤0.01%	1008
2023 Q2	$1.63M	Buy	+10,674	New	+$1.66M	﹤0.01%	966

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Corient Private Wealth's FBT Position: Q2 2026 in Review

Corient Private Wealth opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 4,016 shares worth $996K. The stake represents ﹤0.01% of the portfolio and ranks #1822 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in FBT as recently as Q4 2025.

Corient Private Wealth first reported a position in FBT in Q2 2023 and has held it in 10 quarters since. The position peaked at $1.69M in Q4 2023. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Corient Private Wealth held 4,016 shares of First Trust NYSE Arca Biotechnology Index Fund worth $996K as of Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund was a new Corient Private Wealth position in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1822 holding.
Corient Private Wealth first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2023 and has held it in 10 quarters since.
Corient Private Wealth's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.69M in Q4 2023.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.